Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Chimia
2025
|
| Subjects: | |
| Online Access: | https://pubmed.ncbi.nlm.nih.gov/40314298/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- When DNA Repair Backfires - Trabectedin Induces DNA Breaks in Active Genes. Takhaveev, Vakil Son, Kook Mor, Visesato Yu, Hobin Dillier, Emma Zilo, Nicola Püllen, Nikolai J L Ivanov, Dmitri Ulrich, Helle D Sturia, Shana J Schärer, Orlando D Trabectedin DNA Repair Humans Antineoplastic Agents, Alkylating DNA Adducts DNA Breaks Many anticancer drugs are ineffective in tumors that have functional DNA repair mechanisms. In contrast, trabectedin, a tetrahydroisoquinoline alkaloid marine natural product, stands out as it is more lethal to cancer cells with active DNA repair, particularly transcription-coupled nucleotide excision repair (TC-NER), making it an intriguing alternative to standard chemotherapeutic agents. To optimize trabectedin's use in precision oncology, it is essential to understand how its toxicity depends on TC-NER. In this study, we reveal that incomplete TC-NER of trabectedin-DNA adducts generates persistent single-strand breaks (SSBs). These adducts are found to obstruct the second of two sequential NER-mediated DNA incisions. By mapping the 3'-hydroxyl groups of SSBs resulting from the first NER incision at trabectedin-DNA adducts, we achieve genome-wide visualization of TC-NER. Our findings show that trabectedin-induced SSBs predominantly occur in the transcribed strands of active genes, accumulating near transcription start sites. This work provides new insights into how trabectedin can be leveraged for targeted cancer therapies and for studying TC-NER and transcription.